NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Funds an investigator's own phase I trial in heart, lung, blood or sleep disease — with every regulatory approval already in hand at award.
Most trial awards include time to get ready. This one does not, and says so in terms that decide whether an application is worth writing.
The trials are investigator-initiated phase I studies of diagnostic and therapeutic interventions for heart, lung, blood and sleep disorders, in adults and children. Single-site or multisite are both fine.
Applicants should be ready to initiate the trial withi…
Investigator-initiated phase I clinical trials of diagnostic and therapeutic interventions for heart, lung, blood and sleep disorders in adults and children, single-site or multisite, with regulatory approvals, drug and placebo supplies and third-party agreements established by the time of award and the trial starting within the first quarter. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up